Clinical Psychopharmacology and Neuroscience

Papers
(The TQCC of Clinical Psychopharmacology and Neuroscience is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
A Review of Behavioral Tests to Evaluate Different Types of Anxiety and Anti-anxiety Effects76
The Role of the SLC Transporters Protein in the Neurodegenerative Disorders73
Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations64
The Psychological Impact of COVID-19 Disease is more Severe on Intensive Care Unit Healthcare Providers: A Cross-sectional Study42
Effects of Non-invasive Neurostimulation on Autism Spectrum Disorder: A Systematic Review39
Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence- Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents32
Cariprazine Add-on in Inadequate Clozapine Response: A Report on Two Cases29
Telephone based Interventions for Psychological Problems in Hospital Isolated Patients with COVID-1926
Vitamin D Supplementation is Beneficial for Children with Autism Spectrum Disorder: A Meta-analysis23
Biomarkers of Major Depressive Disorder: Knowing is Half the Battle21
Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis21
Personalization of Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder According to the Existing Psychiatric Comorbidity20
Role of Transcranial Direct Current Stimulation in the Management of Alzheimer’s Disease: A Meta-analysis of Effects, Adherence and Adverse Effects20
Clozapine in the Time of COVID-1919
Korean Medication Algorithm for Schizophrenia 2019, Second Revision: Treatment of Psychotic Symptoms19
Elevated Monocyte to High-density Lipoprotein Ratios as an Inflammation Markers for Schizophrenia Patients18
Second-to-Fourth Digit Ratio (2D:4D) in Psychiatric Disorders: A Systematic Review of Case-control Studies18
White Matter Alterations Associated with Pro-inflammatory Cytokines in Patients with Major Depressive Disorder17
Associations between Exposure to Bisphenol A and Behavioral and Cognitive Function in Children with Attention-deficit/Hyperactivity Disorder: A Case-control Study16
Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder16
Standardization of the Korean Version of the Patient Health Questionnaire-4 (PHQ-4)16
Computational Neuroscience Approach to Psychiatry: A Review on Theory-driven Approaches15
Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea14
Drug-induced Hyperthermic Syndromes in Psychiatry14
Decline in Hospital Visits by Patients with Schizophrenia Early in the COVID-19 Outbreak in Korea14
Apathy: Neurobiology, Assessment and Treatment14
How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach14
Psychobiotic Therapy: Method to Reinforce the Immune System13
Recent Advances in the Pharmacology of Tardive Dyskinesia13
The Neurochemical Effects of Prazosin Treatment on Fear Circuitry in a Rat Traumatic Stress Model13
Associations between the Mismatch-negativity Potential and Symptom Severity in Medication-naïve Children and Adolescents with Symptoms of Attention Deficit/hyperactivity Disorder13
Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments12
Trazodone Add-on in COVID-19-related Selective Serotonin Reuptake Inhibitor-resistant Post-traumatic Stress Disorder in Healthcare Workers: Two Case Reports12
Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis11
Effects of Paliperidone Palmitate on Healthcare Utilization and Costs for Patients with Schizophrenia: A Claim-based Mirror-image Study in South Korea11
High Serum Levels of Serum 100 Beta Protein, Neuron-specific Enolase, Tau, Active Caspase-3, M30 and M65 in Children with Autism Spectrum Disorders11
Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress11
Improved Executive Functions and Reduced Craving in Youths with Methamphetamine Addiction: Evidence from Combined Transcranial Direct Current Stimulation with Mindfulness Treatment11
Evaluation Expression of the Caspase-3 and Caspase-9 Apoptotic Genes in Schizophrenia Patients11
Autism-like Behaviors in Male Juvenile Offspring after Maternal Glyphosate Exposure11
Anxiety, Depression and Burnout Levels of Turkish Healthcare Workers at the End of the First Period of COVID-19 Pandemic in Turkey10
Magnesium Increases the Protective Effect of Citicoline on Aluminum Chloride-induced Cognitive Impairment10
Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology10
miR-132 and miR-942 Expression Levels in Children with Attention Deficit and Hyperactivity Disorder: A Controlled Study9
Lithium Stabilizes the Mood of Bipolar Patients by Depolarizing the Neuronal Membrane Via Quantum Tunneling through the Sodium Channels9
‘Z-trip’? A Comprehensive Overview and a Case-series of Zolpidem Misuse9
Add-on Cariprazine in Patients with Long-term Clozapine Treatment and Treatment Resistant Schizophrenia: Two Cases of Psychotic Deterioration and Pisa Syndrome9
Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia9
Effect of Self-administered Transcranial Direct Stimulation in Patients with Major Depressive Disorder: A Randomized, Single-blinded Clinical Trial9
Rapid Symptom Improvement in Major Depressive Disorder Using Accelerated Repetitive Transcranial Magnetic Stimulation8
Neurological Adverse Reactions to SARS-CoV-2 Vaccines8
Does the Loudness Dependence of Auditory Evoked Potential Predict Response to Selective Serotonin Reuptake Inhibitors?: A Meta-analysis8
Relationship Between the Loudness Dependence of the Auditory Evoked Potential and the Severity of Suicidal Ideation in Patients with Major Depressive Disorder8
The Clinical Observation of Inflammation Theory for Depression: The Initiative of the Formosa Long COVID Multicenter Study (FOCuS)8
Proposed Pathway Linking Respiratory Infections with Depression8
A Neurofeedback Protocol for Executive Function to Reduce Depression and Rumination: A Controlled Study8
Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications8
Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary8
Significant Shortening of Leukocyte Telomere Length in Korean Patients with Bipolar Disorder 18
Higher Prevalence of Metabolic Syndrome in Child-adolescent Patients with Bipolar Disorder7
Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors7
Prescription Patterns for Bipolar Disorder in Asian Countries: Findings from Research on Asian Prescription Pattern-Bipolar Disorder7
Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?7
Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report7
Prediction of Locomotor Activity by Infrared Motion Detector on Sleep-wake State in Mice7
A Different View on the Etiopathogenesis of Attention-deficit Hyperactivity Disorder from an Inflammation Perspective7
Quantitative Resting State Electroencephalography in Patients with Schizophrenia Spectrum Disorders Treated with Strict Monotherapy Using Atypical Antipsychotics7
First Manic Attack During COVID-19 Treatment: A Case Report7
Repetitive Transcranial Magnetic Stimulation for Treatment of Trichotillomania: Case Series7
Network Structures of Social Functioning Domains in Schizophrenia and Bipolar Disorder: A Preliminary Study7
Vortioxetine Treatment for Depression in Alzheimer’s Disease: A Randomized, Double-blind, Placebo-controlled Study7
The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines7
Effectiveness and Tolerability of Korean Red Ginseng Augmentation in Major Depressive Disorder Patients with Difficult-to-treat in Routine Practice7
Methyl Jasmonate: Behavioral and Molecular Implications in Neurological Disorders6
Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors6
Adherence to Antipsychotic Drugs by Medication Possession Ratio for Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A Retrospective Cohort Study6
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia6
Vortioxetine Induced Hypomania: A Case Presentation and Review of the Literature6
Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms6
Predictors of Remission in Acute and Continuation Treatment of Depressive Disorders6
Thiol/Disulfide Homeostasis in Bipolar and Unipolar Depression6
Body Mass Index and Somatic Symptom Severity in Patients with Somatic Symptom Disorder: The Mediating Role of Working Memory6
COVID-19 Impact on the Italian Community-based System of Mental Health Care: Reflections and Lessons Learned for the Future5
Increased Serum Brain-derived Neurotrophic Factor, Nerve Growth Factor, Glial-derived Neurotrophic Factor and Galanin Levels in Children with Attention Deficit Hyperactivity Disorder, and the Effect o5
Baclofen-induced Changes in the Resting Brain Modulate Smoking Cue Reactivity: A Double-blind Placebo-controlled Functional Magnetic Resonance Imaging Study in Cigarette Smokers5
Interactive Effects of Serum Leptin Levels and Physical Comorbidity on the Pharmacotherapeutic Response of Depressive Disorders5
Decreased Cortical Thickness and Local Gyrification in Individuals with Subjective Cognitive Impairment5
Brain-derived Neurotrophic Factor and High Sensitive C-reactive Protein in Bipolar Depression and Unipolar Depression: The Practical Usage as a Discriminatory Tool5
Lurasidone in Therapy of Treatment-resistant Ultra-rapid Cycling Bipolar Disorder: Case Report5
Effectiveness of N-acetylcysteine in Treating Clinical Symptoms of Substance Abuse and Dependence: A Meta-analysis of Randomized Controlled Trials5
Selective Serotonin Reuptake-Inhibitors for Symptom-Based Treatment of Borderline Personality Disorders in Older Adults: An International Delphi Study5
Clinical Usefulness of Amisulpride Add-on Therapy in Schizophrenia Patients without Treatment Response to Second-generation Antipsychotics5
Anhedonia and Depressive Disorders5
Long-term Safety and Efficacy of Esketamine Nasal Spray Plus an Oral Antidepressant in Patients with Treatment-resistant Depression– an Asian Sub-group Analysis from the SUSTAIN-2 Study5
Prediction Models for Suicide Attempts among Adolescents Using Machine Learning Techniques5
Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary5
Neutrophil-lymphocyte and Platelet-lymphocyte Ratios among Adolescents with Substance Use Disorder: A Preliminary Study5
Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease5
Associations among High Risk for Sleep-disordered Breathing, Related Risk Factors, and Attention Deficit/Hyperactivity Symptoms in Elementary School Children5
A Study of Psychological Factors Associated with Functional Gastrointestinal Disorders and Use of Health Care5
DNA Methylation Pattern of Gene Promoters of MB-COMT, DRD2, and NR3C1 in Turkish Patients Diagnosed with Schizophrenia5
Effect of Haloperidol and Risperidone on Serum Melatonin and GAP-43 in Patients with Schizophrenia: A Prospective Cohort Study5
0.055753946304321